Project Grant HT94252411024
Award Date
8/15/24
Completion Date
8/14/27
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This $1,529,953 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Miami to understand the genomic landscape of endometrial cancer in Black women. The project aims to advance scientific understanding of this disease and its impact on a population that is disproportionately affected. The research will be conducted by the University of Miami's Office of Research Administration -...
This $544,250 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of North Carolina at Chapel Hill to develop combination therapies to overcome chemoresistance in Ewing sarcoma. The research project, which has a performance period from August 15, 2024 to August 14, 2027, aims to advance innovative therapeutic approaches to improve outcomes for this rare and aggressive form of cancer. As a...
This federal Project Grant award, valued at $1,541,280.00 and awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the "The Breast Cancer Cellular Atlas" research initiative at the University of North Carolina at Chapel Hill (UNC-CH). This 4-year grant, commencing on March 1, 2025, will fund innovative biomedical research focused on transforming healthcare for military service members and the public. Through this...
This federal Project Grant award of $1,511,536.00 from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports a study on testis cancer survivorship led by the University of North Carolina at Chapel Hill. The award, effective from July 1, 2024 to June 30, 2028, will fund innovative biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The University of North Carolina at...
This federal Project Grant award in the amount of $4,503,963 was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports a research project titled "Spatial Reprogramming of Tumor Immune Microenvironments by Preoperative Radiotherapy and Immune Checkpoint Inhibition in HER2 Negative Breast Cancer." The project is being led by the University of North Carolina at Chapel Hill (UNC-CH) through its Office of Sponsored...
This Defense Health Agency Project Grant award of $1,204,899 to Duke University, with a period of performance from January 1, 2024 to December 31, 2027, supports targeted vaccination research to treat and prevent endocrine-resistant ER+ breast cancer. The project aims to develop new treatments by targeting common resistance genes and neoepitope mutations. This grant is funded through the Department of Defense's Military Medical Research and Development program (CFDA 12.420), which supports...
This Department of Defense Project Grant award in the amount of $1,215,057, effective September 1, 2023, supports a 3-year research project titled "TARGETING NNMT TO INHIBIT OBESITY-ASSOCIATED BREAST CANCER DEVELOPMENT AND PROGRESSION". The award was made to the University of Kentucky Research Foundation under the Military Medical Research and Development (CFDA 12.420) federal grant program. This program funds a range of biomedical research to transform healthcare for Service...
The Defense Health Agency awarded a Project Grant titled "TARGETING EHMT1/2 TO OVERCOME THERAPY-RESISTANT OVARIAN CANCER" to the University of Colorado-Denver in the amount of $1,260,839.00 on May 1, 2025. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The grant aims to investigate innovative...
The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The University of North Carolina at Chapel Hill will receive $3,863,892 under a four-year Project Grant from the Defense Health Agency to integrate molecular pathology, radiology, and genetics to improve breast cancer risk prediction. The grant, awarded on September 15, 2023 under the Military Medical Research and Development program, will support the university's efforts to transform military and public health care by investigating medical solutions for the battlefield and innovative research...